For Clinics

B2B resources and operational guidance for ketamine and psychedelic clinic owners.

Ketamine Patients and GLP-1 Patients Are Often the Same People

47 percent of peptide clinics now offer a GLP-1. Depression, drinking and metabolic disease cluster in the same patients.

Read More

MindMetrix Wants to Fix the First Step in Mental Health Care: The Diagnosis

A Chicago company is betting that better mental health treatment starts with a better assessment. MindMetrix has built a comprehensive

Read More

Every Psychedelic Company Is Racing to Get the Patient Out of the Chair Faster

Lilly paid up to $3.8 billion for a compound whose selling point is a two hour clinic visit. Session length,

Read More

Eli Lilly Buys 5-MeO-DMT Developer AtaiBeckley for Up to $3.8 Billion, the Largest Psychedelic Deal Yet

Eli Lilly, the world’s largest pharmaceutical company, confirmed Thursday morning that it will acquire AtaiBeckley in a deal worth up

Read More

Pharma Is Now Bidding on the Keywords Your Clinic Buys

Johnson & Johnson, Mindbloom and BetterU are all bidding on generic psychedelic search terms. Here is what that does to

Read More

Cluster Headaches Have New Trial Data. Ketamine Clinics Should Be Paying Attention

Two 2024 randomized trials cut cluster headache attacks with pulse dose psilocybin. Where ketamine sits, why these patients overlap with

Read More

What Todd Blanche’s Attorney General Nomination Could Mean for Psychedelics

A recent JD Supra analysis looks at what Todd Blanche’s nomination for attorney general could mean for marijuana and psychedelic

Read More

A Federal Report Just Told States to Prepare for Psychedelic Approval. Ketamine Clinics Are the Template

SAMHSA told states to build the budget, licensing, and oversight machinery for psychedelic therapy before the FDA approves anything. Ketamine

Read More

Ketamine May Relieve Pain Without Relying on Dissociation

Ketamine can reduce pain while producing an altered sense of self. A new study suggests they may travel along separate

Read More

Medicaid Is the Largest Behavioral Health Payer. A New Report Asks What Happens Next

A Center for Health Care Strategies report examines how psychedelic-assisted therapy could reach Medicaid. Some states already cover off-label IV

Read More

Explore Psychedelic Therapy Regions